These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 27131353)

  • 1. Efficacy of Low-Dose Tocilizumab on Relapsing Adult-Onset Still's Disease.
    Vandemergel X; Vandergheynst F
    Acta Medica (Hradec Kralove); 2016; 59(1):22-5. PubMed ID: 27131353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of tocilizumab therapy in Korean patients with adult-onset Still's disease: a multicentre retrospective study of 22 cases.
    Song ST; Kim JJ; Lee S; Kim HA; Lee EY; Shin KC; Lee JH; Lee KH; Choi ST; Cha HS; Yoo DH
    Clin Exp Rheumatol; 2016; 34(6 Suppl 102):S64-S71. PubMed ID: 27462914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of tocilizumab on preventing relapses in adult-onset Still's disease: A retrospective, single-center study.
    Nishina N; Kaneko Y; Kameda H; Takeuchi T
    Mod Rheumatol; 2015 May; 25(3):401-4. PubMed ID: 25401229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tocilizumab in adult-onset Still's disease: the Israeli experience.
    Elkayam O; Jiries N; Dranitzki Z; Kivity S; Lidar M; Levy O; Ablin J; Abu-Shakra M; Savargyl-Maman H; Padova H; Caspi D; Rosner I
    J Rheumatol; 2014 Feb; 41(2):244-7. PubMed ID: 24429168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tocilizumab in patients with adult-onset still's disease refractory to glucocorticoid treatment: a randomised, double-blind, placebo-controlled phase III trial.
    Kaneko Y; Kameda H; Ikeda K; Ishii T; Murakami K; Takamatsu H; Tanaka Y; Abe T; Takeuchi T
    Ann Rheum Dis; 2018 Dec; 77(12):1720-1729. PubMed ID: 30279267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adult-onset Still's disease in a patient over 80 years old successfully treated with low-dose methotrexate therapy.
    Kurasawa M; Kotani K; Kurasawa G; Shida K; Yamada S; Tago T
    Age Ageing; 2007 Jan; 36(1):104-6. PubMed ID: 17158115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of refractory adult onset Still's disease with tocilizumab-a single centre experience and literature review.
    Reihl Crnogaj M; Čubelić D; Babić A; Mayer M; Anić B
    Rheumatol Int; 2020 Aug; 40(8):1317-1325. PubMed ID: 32506202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of adult-onset Still's disease with tocilizumab monotherapy: two case reports and literature review.
    Sakai R; Nagasawa H; Nishi E; Okuyama A; Takei H; Kurasawa T; Kondo T; Nishimura K; Shirai Y; Ito T; Kameda H; Takeuchi T; Amano K
    Clin Rheumatol; 2012 Mar; 31(3):569-74. PubMed ID: 22215118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term safety of tocilizumab treatment on chronic active hepatitis C in a patient with adult onset Still's disease.
    Forestier E; Pasquali JL
    Joint Bone Spine; 2015 Mar; 82(2):136-7. PubMed ID: 25553837
    [No Abstract]   [Full Text] [Related]  

  • 10. Case report: successful use of short-term add-on tocilizumab for multirefractory systemic flare of adult-onset Still's disease.
    Naniwa T; Ito R; Watanabe M; Hayami Y; Maeda S; Sasaki K; Iwagaitsu S
    Clin Rheumatol; 2013 Mar; 32 Suppl 1():S103-6. PubMed ID: 20842515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful tocilizumab therapy in seven patients with refractory adult-onset Still's disease.
    Bannai E; Yamashita H; Kaneko S; Ueda Y; Ozaki T; Tsuchiya H; Takahashi Y; Kaneko H; Kano T; Mimori A
    Mod Rheumatol; 2016; 26(2):297-301. PubMed ID: 24697199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of tocilizumab in conventional treatment-refractory adult-onset Still's disease: multicenter retrospective open-label study of thirty-four patients.
    Ortiz-Sanjuán F; Blanco R; Calvo-Rio V; Narvaez J; Rubio Romero E; Olivé A; Castañeda S; Gallego Flores A; Hernández MV; Mata C; Ros Vilamajo I; Sifuentes Giraldo WA; Caracuel MA; Freire M; Gómez Arango C; Llobet J; Manrique Arija S; Marras C; Moll-Tuduri C; Plasencia-Rodriguez C; Roselló R; Urruticoechea A; Velloso-Feijoo ML; Del Blanco J; González-Vela MC; Rueda-Gotor J; Pina T; Loricera J; González-Gay MA
    Arthritis Rheumatol; 2014 Jun; 66(6):1659-65. PubMed ID: 24515813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two cases of adult-onset Still's disease treated with tocilizumab that achieved tocilizumab-free remission.
    Kobayashi D; Ito S; Murasawa A; Narita I; Nakazono K
    Intern Med; 2015; 54(20):2675-9. PubMed ID: 26466710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of subcutaneous tocilizumab in refractory adult Still's disease: report of three cases and a review of the literature.
    Torigoe M; Maeshima K; Kuriyama Y; Abe I; Ozaki T; Omura Y; Umeki T; Imada C; Ishii K; Shibata H
    Mod Rheumatol Case Rep; 2021 Jul; 5(2):365-370. PubMed ID: 33560182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case report of a patient with refractory adult-onset Still's disease who was successfully treated with tocilizumab over 6 years.
    Nakahara H; Mima T; Yoshio-Hoshino N; Matsushita M; Hashimoto J; Nishimoto N
    Mod Rheumatol; 2009; 19(1):69-72. PubMed ID: 18762861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of sarilumab in adult-onset Still's disease as a corticosteroid-sparing agent.
    Simeni Njonnou SR; Soyfoo MS; Vandergheynst FA
    Rheumatology (Oxford); 2019 Oct; 58(10):1878-1879. PubMed ID: 31056689
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful tocilizumab treatment in a patient with adult-onset Still's disease complicated by chronic active hepatitis B and amyloid A amyloidosis.
    Kishida D; Okuda Y; Onishi M; Takebayashi M; Matoba K; Jouyama K; Yamada A; Sawada N; Mokuda S; Takasugi K
    Mod Rheumatol; 2011 Apr; 21(2):215-8. PubMed ID: 20931272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal time of starting tocilizumab in acute phase of adult-onset Still's disease and comparison of its efficacy with that of methotrexate: a case series and a review of the literature.
    Suzuki S; Kataoka Y; Otani T; Taniguchi Y; Ikeda K; Tamura N; Morimoto S
    Clin Rheumatol; 2024 Mar; 43(3):1245-1251. PubMed ID: 38342797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urticarial rash, fever, and arthritis: A case of refractory Adult-onset Still's disease with good response to tocilizumab.
    Wawrzycki B; Krasowska D; Pietrzak A; Wielosz E; Majdan M; Lotti T
    Dermatol Ther; 2019 Sep; 32(5):e13041. PubMed ID: 31361930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tocilizumab effectiveness in adult Still's disease].
    López Buitrago R; Estrada Dorronsoro S; Cervera Segura R; Espinosa Garriga G
    Med Clin (Barc); 2012 Jan; 138(1):42-3. PubMed ID: 21605875
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.